These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 12495846)

  • 1. PTEN and myotubularin phosphatases: from 3-phosphoinositide dephosphorylation to disease.
    Wishart MJ; Dixon JE
    Trends Cell Biol; 2002 Dec; 12(12):579-85. PubMed ID: 12495846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTEN and myotubularin phosphoinositide phosphatases: bringing bioinformatics to the lab bench.
    Wishart MJ; Taylor GS; Slama JT; Dixon JE
    Curr Opin Cell Biol; 2001 Apr; 13(2):172-81. PubMed ID: 11248551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN and myotubularin: novel phosphoinositide phosphatases.
    Maehama T; Taylor GS; Dixon JE
    Annu Rev Biochem; 2001; 70():247-79. PubMed ID: 11395408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. I-proteins - a proposed switch in myotubularin function.
    Clague MJ; Dove SK; Barr FA
    Trends Biochem Sci; 2004 Feb; 29(2):58-61. PubMed ID: 15102431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN and myotubularins: families of phosphoinositide phosphatases.
    Taylor GS; Dixon JE
    Methods Enzymol; 2003; 366():43-56. PubMed ID: 14674238
    [No Abstract]   [Full Text] [Related]  

  • 6. Antagonism of PI 3-kinase-dependent signalling pathways by the tumour suppressor protein, PTEN.
    Downes CP; Bennett D; McConnachie G; Leslie NR; Pass I; MacPhee C; Patel L; Gray A
    Biochem Soc Trans; 2001 Nov; 29(Pt 6):846-51. PubMed ID: 11709086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
    Freeburn RW; Wright KL; Burgess SJ; Astoul E; Cantrell DA; Ward SG
    J Immunol; 2002 Nov; 169(10):5441-50. PubMed ID: 12421919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN as an effector in the signaling of antimigratory G protein-coupled receptor.
    Sanchez T; Thangada S; Wu MT; Kontos CD; Wu D; Wu H; Hla T
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4312-7. PubMed ID: 15764699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid phosphatases in the regulation of T cell activation: living up to their PTEN-tial.
    Seminario MC; Wange RL
    Immunol Rev; 2003 Apr; 192():80-97. PubMed ID: 12670397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphoinositide signaling disorders in human diseases.
    Pendaries C; Tronchère H; Plantavid M; Payrastre B
    FEBS Lett; 2003 Jul; 546(1):25-31. PubMed ID: 12829232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphatases as small-molecule targets: inhibiting the endogenous inhibitors of kinases.
    Schmid AC; Woscholski R
    Biochem Soc Trans; 2004 Apr; 32(Pt 2):348-9. PubMed ID: 15046606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphoinositide phosphatases in a network of signalling reactions.
    Blero D; Payrastre B; Schurmans S; Erneux C
    Pflugers Arch; 2007 Oct; 455(1):31-44. PubMed ID: 17605038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the PTEN phosphatase.
    Gericke A; Munson M; Ross AH
    Gene; 2006 Jun; 374():1-9. PubMed ID: 16675164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of platelet-derived growth factor receptor by the tumor suppressor PTEN provides a novel mechanism of action of the phosphatase.
    Mahimainathan L; Choudhury GG
    J Biol Chem; 2004 Apr; 279(15):15258-68. PubMed ID: 14718524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity.
    Koul D; Jasser SA; Lu Y; Davies MA; Shen R; Shi Y; Mills GB; Yung WK
    Oncogene; 2002 Apr; 21(15):2357-64. PubMed ID: 11948419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lipid phosphatase activity of PTEN is critical for its tumor supressor function.
    Myers MP; Pass I; Batty IH; Van der Kaay J; Stolarov JP; Hemmings BA; Wigler MH; Downes CP; Tonks NK
    Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13513-8. PubMed ID: 9811831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An assay for phosphoinositide phosphatases utilizing fluorescent substrates.
    Taylor GS; Dixon JE
    Anal Biochem; 2001 Aug; 295(1):122-6. PubMed ID: 11476556
    [No Abstract]   [Full Text] [Related]  

  • 18. Inositol lipid phosphatases in membrane trafficking and human disease.
    Billcliff PG; Lowe M
    Biochem J; 2014 Jul; 461(2):159-75. PubMed ID: 24966051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphatidylinositol-5-phosphate activation and conserved substrate specificity of the myotubularin phosphatidylinositol 3-phosphatases.
    Schaletzky J; Dove SK; Short B; Lorenzo O; Clague MJ; Barr FA
    Curr Biol; 2003 Mar; 13(6):504-9. PubMed ID: 12646134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphoinositide phosphatases in cell biology and disease.
    Liu Y; Bankaitis VA
    Prog Lipid Res; 2010 Jul; 49(3):201-17. PubMed ID: 20043944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.